With box warnings

Without box warnings

Branded

Generic

4 results

avastin
(bevacizumab)
Genentech, Inc.
Usage: Avastin is indicated for the treatment of various cancers, including metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent or recurrent cervical cancer, and advanced epithelial ovarian or peritoneal cancers, often in combination with other chemotherapy agents.
vectibix
(panitumumab)
Amgen Inc
Usage: Vectibix is indicated for the treatment of adult patients with wild-type RAS metastatic colorectal cancer (mCRC) as first-line therapy with FOLFOX or as monotherapy after prior chemotherapy. It is also approved for KRAS G12C-mutated mCRC in combination with sotorasib in previously treated patients.
zaltrap
(ziv-aflibercept)
sanofi-aventis U.S. LLC
Usage: ZALTRAP, combined with fluorouracil, leucovorin, and irinotecan (FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed after treatment with an oxaliplatin-containing regimen.
zirabev
(bevacizumab-bvzr)
Pfizer Laboratories Div Pfizer Inc
Usage: ZIRABEV is indicated for treating metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent glioblastoma, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer, and advanced epithelial ovarian/fallopian tube/peritoneal cancer, often in combination with other chemotherapy agents.

Medications for Metastatic Colorectal Carcinoma

avastin